Scandoil  

Halliburton and Baker Hughes respond to European Commission action


Published Jan 14, 2016
Halliburton-2

Halliburton Company and Baker Hughes Incorporated noted the decision by the European Commission (the “Commission”) to initiate a Phase II review of Halliburton’s pending acquisition of Baker Hughes.

This decision is a normal step in the Commission's review process, and the views expressed by the Commission at this stage are preliminary only. Pursuant to applicable regulations, Phase II generally provides the Commission with 90 working days to review the pending transaction. Halliburton and Baker Hughes will continue to work constructively with the Commission.

Although the Commission was kept informed of the remedies that Halliburton has proposed to the U.S. Department of Justice, Halliburton did not offer remedies during Phase I, as it believes that offering remedies during Phase II will facilitate a more efficient review. Halliburton expects to offer a substantial remedies package that it believes will address any substantive competition concerns.

Tags: Baker Hughes Incorporated, Halliburton




Advertisment:

Add a Comment to this Article

Please be civil. Job and promotion will not be added into the comment page.

(Use Markdown for formatting.)

This question helps prevent spam:

+ Larger Font | + Smaller Font
Top Stories

 

 

 

 


 


RSS

RSS
Newsletter
Newsletter
Mobile News
Mobile news

Computer
Our news on
your website


Facebook
Facebook
Twitter
Twitter

Contact
Contact
Tips
Do you have any
tips to us
Stats

 

sitemap xml